Peter D. Kies
2013
In 2013, Peter D. Kies earned a total compensation of $499.1K as Chief Financial Officer at Inovio Pharmaceuticals, a 8% increase compared to previous year.
Compensation breakdown
| Bonus | $103,147 |
|---|---|
| Option Awards | $71,392 |
| Salary | $318,833 |
| Other | $5,755 |
| Total | $499,127 |
Kies received $318.8K in salary, accounting for 64% of the total pay in 2013.
Kies also received $103.1K in bonus, $71.4K in option awards and $5.8K in other compensation.
Rankings
In 2013, Peter D. Kies' compensation ranked 9,376th out of 12,286 executives tracked by ExecPay. In other words, Kies earned more than 23.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,376 out of 12,286 | 24th |
Division Manufacturing | 3,445 out of 4,612 | 25th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 460 out of 677 | 32nd |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 280 out of 416 | 33rd |
Industry Surgical and Medical Instruments and Apparatus | 166 out of 259 | 36th |
Source: SEC filing on March 25, 2016.
Kies' colleagues
We found three more compensation records of executives who worked with Peter D. Kies at Inovio Pharmaceuticals in 2013.
News
Inovio Pharmaceuticals CEO Jacqueline Shea's 2023 pay falls 31% to $2.4M
April 11, 2024
Inovio Pharmaceuticals CEO J Kim's 2022 pay jumps 68% to $10M
March 28, 2023
Inovio Pharmaceuticals CEO J Kim's 2021 pay jumps 32% to $6.2M
March 25, 2022
Inovio Pharmaceuticals CEO J Kim's 2020 pay jumps 82% to $4.7M
March 25, 2021
Inovio Pharmaceuticals CEO J Kim's 2018 pay falls 30% to $3.1M
March 25, 2019